Business Directory, Press Releases, Jobs, Products, Services, Articles
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | News on Your Site

Press Releases


Press Release

Receive press releases from CNBE: By Email RSS Feeds:

A Strike Force in Biomarker Discovery in Animals is Now Available. Strategic Alliance Between Eve Technologies and CNBE INRS.

Laval, Canada, December 15, 2017 --( A strategic partnership agreement in biomarker discovery was signed by Eve Technologies and Centre national de biologie expérimentale (CNBE) of Institut national de recherche scientifique (INRS). This unique alliance provides integrated contractual services from animal studies to biomarker identification and measurement in numerous animal species. Their services facilitate protein analysis and drug discovery by providing reproducible, quantitative immunoassay data from a small sample volume from healthy animals and animal models for human disease.

The spectrum of services comprises hundreds of multiplexing targets including cytokines, chemokines, toxicology markers, cancer markers, cardio markers, metabolic markers and neuroscience markers in mouse, rat, dog, swine, sheep and non-human primate.

Eve Technologies, with over 15 years of experience, is responsible to provide assay services and results to the world’s leading researchers, biotechnology and pharmaceutical companies. Eve Technologies has become leader in the industry assisting over 1000 research institutions with the best solutions for their projects. CNBE, with over 22 years of experience, is responsible for the in-life part including drug administration, clinical assessment, and blood and sample collections. CNBE is a state-of-art animal facility fully accredited by the Canadian council on animal care (CCAC) and AAALAC International having expertise with many animal species from rodents to non-human primates. CNBE has developed many animal models in different therapeutic areas (e.g. oncology, immunology, liver injury, endotoxemia), may develop models according to your needs and offers non-GLP exploratory studies in toxicology and pharmacokinetic.

Thanks to this agreement, the clients will be able to use the expertise of each organisation to strengthen their drug development pipeline.

About Eve Technologies Corp
Eve Technologies is an independent corporation based on Calgary, AB, Canada that solely exists to partner with biomedical and life science researchers. To best serve our clients, we have focused on gaining expertise in the most effective assay technology that we know of – multiplexing laser beads. By utilizing this technology, Eve Tech aims to provide the biomedical and life science community with the highest quality assay services at the most cost-effective prices. As a result of developing advanced assay techniques, employing automation and forming strong relationships with suppliers, we offer the most affordable assay services in the industry.

CNBE, located on the INRS Research University campus in Laval, Québec, Canada, offers high standard preclinical research services to the scientific community and the biotechnology and pharmaceutical industries. Certified by the Canadian Council on Animal Care in Science (CCAC) and the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International), it provides housing for laboratory animals at various levels of biological confinement as well as an array of services required by R&D projects and drug development.


Mark L. Fritzler Mario C Filion
Operations Manager Director
Eve Technologies Corp CNBE INRS
Calgary, Alberta, Canada Laval, Québec, Canada
Contact Information
MC Filion
450 687 5010

Click here to view the list of recent Press Releases from CNBE
Promote Your Business